About the Authors

Min Jun

Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

mjun@georgeinstitute.org.au

Affiliation The George Institute for Global Health, UNSW Sydney, Sydney, Australia

Meg J. Jardine

Roles Conceptualization, Writing – review & editing

Affiliation The George Institute for Global Health, UNSW Sydney, Sydney, Australia

Vlado Perkovic

Roles Writing – review & editing

Affiliation The George Institute for Global Health, UNSW Sydney, Sydney, Australia

Quentin Pilard

Roles Formal analysis, Methodology, Software, Validation, Writing – review & editing

Affiliation The George Institute for Global Health, UNSW Sydney, Sydney, Australia

Laurent Billot

Roles Methodology, Writing – review & editing

Affiliation The George Institute for Global Health, UNSW Sydney, Sydney, Australia

Anthony Rodgers

Roles Writing – review & editing

Affiliation The George Institute for Global Health, UNSW Sydney, Sydney, Australia

Kris Rogers

Roles Methodology, Validation, Writing – review & editing

Affiliation The George Institute for Global Health, UNSW Sydney, Sydney, Australia

Martin Gallagher

Roles Writing – review & editing

Affiliation The George Institute for Global Health, UNSW Sydney, Sydney, Australia

Competing Interests

This study was funded by AstraZeneca Proprietary Limited and commissioned by VentureWise (a wholly owned commercial subsidiary of NPS MedicineWise). MJ reports no conflicts of interest. MJJ is responsible for research projects that have received unrestricted funding from Gambro, Baxter, CSL, Amgen, Eli Lilly, and Merck; has served on advisory boards sponsored by Akebia, Baxter and Boehringer Ingelheim, spoken at scientific meetings sponsored by Janssen, Amgen and Roche; with any consultancy, honoraria or travel support paid to her institution. VP has participated in advisory boards for both Relypsa and AstraZeneca and has received honoraria and consultation fees from Tricida, Novartis, Amgen, Janssen, GlaxoSmithKline, Astellas, Boeringer Ingelheim, Baxter, Mitsubishi Tanabe, Retrophin, Merck, Abbvie, Novo Nordisk, AstraZeneca, Gilead, Durect, Servier, Eli Lilly, Relypsa, Pharmalink, Bayer, Bristol-Myers Squibb and Tufts, with payments paid to his institution. MG reports receiving honoraria from Shire and Amgen for speaking at scientific meetings. QP, LB, AR and KR report no conflicts of interest. Reported competing interests do not alter our adherence to PLOS ONE policies on sharing data and materials.